Outcomes vary: Mild cases may improve with treatment Moderate cases may require long-term management Severe cases can become permanent Some patients develop lifelong GI dysfunction after GLP-1 drug use Early diagnosis significantly improves prognosis
market entry means starting over at Phase I or II despite strong ex-U.S
Tail spasticity Interestingly, the development of spasticity began earlier in the rats that underwent spinal cord injury and had been treated with BPC 157 than in the corresponding controls
Partial muscle carnitine palmitoyltransferase-A deficiency
While such models provide significant mechanistic insights into APAP-induced hepatotoxicity, including pathways related to oxidative stress, mitochondrial dysfunction, and inflammasome activation, they may not fully recapitulate the complexity of human physiology
The authors also attempted to address some universally shared gaps in KDT provision and management in the long term, thus making these recommendations of interest for all KDT services, regardless of their geographical location